(Q44710313)

5 December 2017

title

Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years (English)

1 reference

5 December 2017

Maria Regina Chalita

1

1 reference

5 December 2017

Ana Luisa Höfling-Lima

2

1 reference

5 December 2017

Augusto Paranhos

3

1 reference

5 December 2017

Paulo Schor

4

1 reference

5 December 2017

Rubens Belfort

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

American Journal of Ophthalmology

5 December 2017

published in

1 reference

5 December 2017

volume

137

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

43-51

1 reference

Decision-making in the Management of Microbial Keratitis

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

In vitro antibiotic resistance in bacterial keratitis in London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Ciprofloxacin-resistant Pseudomonas keratitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Corneal ulceration at an urban African hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Spectrum of microbial keratitis in South Florida.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Antibiotic sensitivity of recent clinical isolates from patients with ocular infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Use of antimicrobials to prevent postoperative infection in patients with cataracts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Quinolone antibacterials. An update of their pharmacology and therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

Role of the fluoroquinolones in ophthalmology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

inferred from DOI database lookup

7 January 2021

based on heuristic

The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900905-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(03)00905-X

1 reference

5 December 2017

1 reference